The Finger Pulse Oximeter is a small portable device that measures % SpO2, pulse rate, and pulse indication on the finger. It may be used as a spot-check device in the home or clinical environment. The pulse oximeter will provide reliable measurements on pediatric patients weighing 35 lbs or more, and on adult patients. This device is not intended for continuous patient monitoring. There are no audible or visible patient alarms.

Device Description

The AccuPulse Oximeter is a portable, lightweight, and battery-operated device that measures %SpO2 and pulse rate on the finger of a patient.

AI/ML Overview

The provided text describes a 510(k) summary for the AccuPulse Oximeter, which relies on demonstrating substantial equivalence to a predicate device (Fox Oximeter). The document contains information about the device's performance through a clinical study.

Here's an analysis based on the provided input:

Acceptance Criteria and Device Performance

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria	Reported Device Performance
Correlation between blood gas and oximetry readings ≤ 2.0%	1.87% correlation between blood gas and oximetry readings

2. Sample Size for Test Set and Data Provenance

Sample Size: Not explicitly stated. The document mentions "a clinical study" was performed but does not quantify the number of patients or samples.
Data Provenance: The clinical data was collected in April 2005 at the Milwaukee VA Medical Center. Anesthesia Research Lab. This indicates prospective data collection in the USA.

3. Number of Experts and their Qualifications for Ground Truth

Not explicitly stated. The clinical study was performed by the "Milwaukee VA Medical Center. Anesthesia Research Lab." This suggests medical professionals were involved in the data collection and analysis, but their specific roles, number, or qualifications for establishing ground truth are not detailed.

4. Adjudication Method for the Test Set

Not explicitly stated. The study involved a "correlation between blood gas and oximetry readings," which implies a direct comparison rather than an adjudication process between multiple readers. Since we don't have details on how "blood gas" readings were obtained or interpreted, we cannot infer an adjudication method.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, a MRMC comparative effectiveness study was not done. The documented clinical study focused on the correlation between device readings and blood gas measurements, not on comparing human readers with and without AI assistance.

6. Standalone (Algorithm Only) Performance Study

Yes, a standalone performance study was implicitly done. The clinical study evaluated the "correlation between blood gas and oximetry readings" for the prototype devices that led to the Fox Oximeter. This assesses the device's (and its underlying algorithm's) ability to accurately measure oxygen saturation and pulse rate against a gold standard (blood gas analysis). The AccuPulse Oximeter uses the same microprocessor and signal processing software (AccuPulse V1.03) as the Fox Oximeter (FOX V1.03), implying the performance of the core algorithm is unchanged from the Fox Oximeter clinical test.

7. Type of Ground Truth Used

Blood gas analysis (e.g., arterial blood gas - ABG). The clinical study measured the "correlation between blood gas and oximetry readings," indicating that blood gas analysis served as the reference standard for oxygen saturation.

8. Sample Size for the Training Set

Not applicable / Not stated. This device is a pulse oximeter, which typically uses established physiological principles and algorithms rather than machine learning models that require distinct "training sets" in the modern AI sense. The reference to "FOX V1.03" and "AccuPulse V1.03" software suggests a pre-programmed algorithm.

9. How the Ground Truth for the Training Set was Established

Not applicable / Not stated. As mentioned above, a traditional "training set" with ground truth in the context of AI/machine learning is not relevant here. The device's underlying algorithm is likely developed based on extensive physiological and engineering data, rather than a specific labeled training set from a clinical study.

Summary

{0}------------------------------------------------

510(k) Summary

1. Submitter's Identification:

Applicant:

Lawrence Pellerito, Principal 3101 West Thomas Road, Suite 108 Phoenix, AZ 85017 Tel: 602-272-2141 Fax: 602-272-1275

MAY 1 1 2007

James A. Dunning, President Correspondent: QualPro Consulting, LLC 537 N. Spencer Mesa, AZ 85203 Tel: 480-703-3631 Fax: 480-461-1961

Date:

11 May 2007

Device Name: 2.

Trade Name:	AccuPulse Oximeter
Common Name:	Finger Pulse Oximeter
Classification Name:	Oximeter

Predicate Device Information: 3.

The legally marketed device to which the submitter claims equivalence is:

Fox Oximeter (K051736)

.4. Device Description:

The AccuPulse Oximeter is a portable, lightweight, and battery-operated device that measures %SpO2 and pulse rate on the finger of a patient.

Indications for Use: 5.

The Finger Pulse Oximeter is a small portable device that measures % SpO2 pulse rate, and pulse indication on the finger. It may be used as a spot-check device in the home or clinical environment. The pulse oximeter will provide reliable measurements on pediatric patients weighing 35 lbs or more, and on adult patients. This device is not intended for continuous patient monitoring. There are no audible or visible patient alarms.

6. Comparison with Predicate Device:

Both the AccuPulse Pulse Oximeter and the Fox Oximeter are designed to monitor %SpO2 and pulse rate. The same critical components and component sources are used for both the Fox Oximeter and the AccuPulse Pulse Oximeter. The AccuPulse Pulse Oximeter uses a circular Light Emitting Diode (LED) indicator to show that the battery is on. The Fox Oximeter does not have a specific battery on indicator, at least one LED will be on at all times, indicating power is on.

Testing was done to ensure that the AccuPulse Pulse Oximeter would perform safely and effectively within the environment(s) for which it is to be marketed.

5/11/2007 Page 1 of 3

{1}------------------------------------------------

7. Discussion on Non-Clinical Test Performed:

The AccuPulse Oximeter complies with the following:

EN 50082-1 .
EN 61000-4-2 ●
EN 61000-4-3 .
. EN 61000-4-8
. EN 55022-1998 with Amendment A1;2000 (CISPR-22)

The following studies were performed on the Elastosil® E 951 (previously known as Elastosil® SWS 951) Control No: 27943 SE material, by BIOSERVICE, Scientific Laboratories GmBH, Munich, BehringStrasse 6, D-82152 Planegg:

. Cytotoxicity
. Hemolysis
. Pryogenicity
. Sensitization
Dermal Irritation .
Implantation (90 days) .

The following studies were performed on the Dow Corning® C6-550 Liquid Silicone Rubber, as described in Dow Corning's "SUMMARY OF QUALIFICATION DATE FOR DOW CORNING ® C6-550 LIQUID SILICONE RUBBER, Revision Date REC 01 Aug 2003":

. Acute Toxicity
. Systemic Toxicity
Intracutaneous Reactivity �
. 30-Day Implant

8. Discussion on Clinical Test Performed:

A clinical study was sponsored by ITEC Engineering, LLC, represented by Daniel Englert and Eugene Palatnik. This clinical study was performed at the Milwaukee VA Medical Center. Anesthesia Research Lab. The clinical data was collected in April 2005. This clinical study showed that the correlation between blood gas and oximetry readings, calculated statistically, is 1.87%, which is well within the target accuracy of not more than 2.0%. This clinical study was performed using prototype devices that lead to the final finished device known as the Fox Oximeter device, which is legally marketed by Biotran, Inc.

ACCUPULSE COMPANY worked with ITEC Engineering, LLC, to establish ACCUPULSE COMPANY as a separate owner/operator to manufacture the pulse oximeter device. ITEC Engineering, LLC and Biotran, Inc. granted ACCUPULSE COMPANY permission to use the components, component sources, and clinical study records originally established for the Fox Pulse Oximeter. ITEC Engineering, LLC, currently programs and supplies the microprocessor and the associated signal processing software (FOX V1.03) for the Fox Finger Pulse Oximeter. ITEC Engineering, LLC, has also programmed and supplied the microprocessor and the associated signal processing software (AccuPulse V1.03) to ACCUPULSE COMPANY for the AccuPulse Pulse Oximeter.

5/11/2007 Page 2 of 3

{2}------------------------------------------------

9. Conclusion:

The AccuPulse Pulse Oximeter (subject device) has the same intended use and theory of operation as the Fox Oximeter (predicate device). Moreover, the critical components and the same component sources are used for both devices. Only minor display differences differentiate the AccuPulse Pulse Oximeter from the predicate device, the Fox Pulse Oximeter. The technological characteristics of the AccuPulse Pulse Oximeter are the same technological characteristics employed by the Fox Pulse Oximeter. The minor display differences do not affect safety or effectiveness of the AccuPulse Oximeter for its intended use. Therefore, the AccuPulse Pulse Oximeter is substantially equivalent to the Fox Oximeter (predicate device).

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized depiction of an eagle with three lines forming its body and wings. The logo is surrounded by a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES, USA" in capital letters. The text is arranged around the circle, following its curvature.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 1 1 2007

Eagle Medical Equipment Compamy C/O Mr. James A. Dunning President QualPro Consulting, LLC 537 N. Spencer Mesa, Arizona 85203

Re: K062724

Trade/Device Name: AccuPulse Pulse Oximeter Model OX1A Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: April 30, 2007 Received: May 1, 2007

Dear Mr. Dunning:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2 - Mr. Dunning

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Chiu Lin, Ph.D.

Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

{5}------------------------------------------------

ACCUPULSE COMPANY

Indications for Use

510(k) Number (if known):

Device Name: AccuPulse Finer Pulse Oximeter

Indications For Use: The Finger Pulse Oximeter is a small portable device that measures % SpO2, pulse rate, and pulse indication on the finger. It may be used as a spot-check device in the home or clinical environment. The pulse oximeter will provide reliable measurements on pediatric patients weighing 35 lbs or more, and on adult patients. This device is not intended for continuous patient monitoring. There are no audible or visible patient alarms.

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Ch. Uffo

non orgh-Off) ിന്നാം വ്യസ-ാനി
Hospital of Anesthesiology, General Hospital, Control, Dental Devices

062724

Page 1 of 1

Regulation Number and Section

§ 870.2700 Oximeter.

(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).